An open-label, multi-center phase 1/2 study of Surufatinib in combination with gemcitabine in pediatric patients with recurrent or refractory solid tumors

Project: Research project

Project Details

Description

An open-label, multi-center phase 1/2 study of Surufatinib in combination with gemcitabine in pediatric patients with recurrent or refractory solid tumors
StatusActive
Effective start/end date6/28/216/27/23

Funding

  • Public Health Institute

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.